Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$130,707,319
-$30,696,938 QoQ
Shares Held
1,034,568
-10.7% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#117
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $2,466,204,715 across 17 Drug Manufacturers - General names. GILD ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
689,850 | $827,426,853 | |
| 2 | JNJ |
Johnson & Johnson
|
1,608,573 | $408,529,284 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,713,402 | $220,172,157 | |
| 4 | ABBV |
AbbVie Inc.
|
728,959 | $183,435,241 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
1,034,568 | $130,707,319 | |
| 6 | AMGN |
Amgen Inc
|
343,610 | $124,428,052 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,153,285 | $124,072,280 | |
| 8 | AZN |
Astrazeneca PLC
|
572,746 | $108,604,096 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,707,319 | 1,034,568 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $161,404,257 | 1,158,099 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $134,119,837 | 1,092,715 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $138,973,554 | 1,252,014 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $104,396,077 | 941,608 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $95,092,687 | 848,663 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $70,234,267 | 760,358 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $53,978,538 | 643,828 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $41,439,135 | 603,981 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $51,656,631 | 705,210 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $67,338,670 | 831,239 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $64,105,772 | 855,428 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $67,810,655 | 879,858 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $73,755,932 | 888,947 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $70,625,360 | 822,660 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $42,622,051 | 690,907 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $36,977,830 | 598,250 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $40,503,165 | 681,298 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $49,505,061 | 681,794 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $54,134,447 | 775,010 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $37,750,772 | 548,225 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $22,148,118 | 342,691 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $18,098,292 | 310,647 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $19,945,669 | 315,646 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $27,878,054 | 362,335 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $26,379,065 | 352,850 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||